Quantifying prognostic impact of prescription opioid use before kidney transplantation through linked registry and pharmaceutical claims data

Transplantation

Volumn 99, Issue 1, 2015, Pages 187-196

  Lentine, Krista L ^a   Yuan, Hui ^a   Tuttle Newhall, Janet E ^a   Xiao, Huiling ^a   Chawa, Vikram ^a   Axelrod, David ^b   Brennan, Daniel C ^c   Dharnidharka, Vikas R ^c   Beuer, Christopher ^a   Schnitzler, Mark A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; CADAVER DONOR; CAUSE OF DEATH; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG USE; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; GROUPS BY AGE; HUMAN; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PRESCRIPTION; PROGNOSIS; PUBLIC HEALTH INSURANCE; RACE DIFFERENCE; REGISTER; RISK; SEX DIFFERENCE; SURVIVAL TIME; YOUNG ADULT; ADOLESCENT; DATA MINING; HEALTH INSURANCE; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; MULTIVARIATE ANALYSIS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; DATA MINING; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; GRAFT SURVIVAL; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84920196782     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000248     Document Type: Article

References (31)

1. Salisbury EM, Game DS, Al-Shakarchi I, et al. Changing practice to improve pain control for renal patients. Postgrad Med J 2009; 85:30.
2. Weisbord SD, Fried LF, Arnold RM, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol 2005;16:2487.
3. Bailie GR, Mason NA, Bragg-Gresham JL, et al. Analgesic prescription patterns among hemodialysis patients in the DOPPS: potential for underprescription. Kidney Int 2004;65:2419.
4. Davison SN. Pain in hemodialysis patients: prevalence, cause, severity, and management. Am J Kidney Dis 2003;42:1239.
5. Kurella M, Bennett WM, Chertow GM. Analgesia in patients with ESRD: a review of available evidence. Am J Kidney Dis 2003;42:217.
6. Barakzoy AS, Moss AH. Efficacy of the world health organization analgesic ladder to treat pain in end-stage renal disease. J Am Soc Nephrol 2006;17:3198.
7. Manchikanti L, HelmS2nd, Fellows B, et al. Opioid epidemic in the United States. Pain Physician 2012;15(3 Suppl):ES9.
8. Falkowski C. The rampant abuse of prescription pain medications. Minn Med 2013;96:38.
9. Labianca R, Sarzi-Puttini P, Zuccaro SM, et al. Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain. Clin Drug Investig 2012;32(Suppl 1):53.
10. Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician 2008;11(2 Suppl):S105.
11. Wilcock A, Beattie JM. Prolonged QT interval and methadone: implications for palliative care. Curr Opin Support Palliat Care 2009;3:252.
12. Atici S, Cinel I, Cinel L, et al. Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model. J Biosci 2005; 30:245.
13. Juurlink DN, Dhalla IA. Dependence and addiction during chronic opioid therapy. J Med Toxicol 2012;8:393.
14. Stein R. FDA Seeks To Tighten Controls On Hydrocodone Painkillers. Health News from NPR, October 24, 2013. http://www.npr.org/blogs/ health/2013/10/24/240569516/fda-seeks-to-tighten-controls-onhydrocodone-painkillers. Access date: November 6, 2013.
15. Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage 2004;28:497.
16. Niscola P, Scaramucci L, Vischini G, et al. The use of major analgesics in patients with renal dysfunction. Curr Drug Targets 2010;11:752.
17. Masajtis-Zagajewska A, Pietrasik P, Krawczyk J, et al. Similar prevalence but different characteristics of pain in kidney transplant recipients and chronic hemodialysis patients. Clin Transplant 2011;25:E144.
18. Barrantes F, Luan FL, Kommareddi M, et al. A history of chronic opioid usage prior to kidney transplantation may be associated with increased mortality risk. Kidney Int 2013;84:390.
19. Morral AR, McCaffrey D, Iguchi MY. Hardcore drug users claim to be occasional users: drug use frequency underreporting. Drug Alcohol Depend 2000;57:193.
20. CepedaMS, Fife D, ChowW, et al. Assessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the US. Drug Saf 2012;35:325.
21. Wandner LD, Heft MW, Lok BC, et al. The impact of patients' gender, race, and age on health care professionals' pain management decisions: an online survey using virtual human technology. Int J Nurs Stud 2013.
22. Rice JB, White AG, Birnbaum HG, et al. A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. Pain Med 2012;13:1162.
23. Han H, Kass PH, Wilsey BL, et al. Increasing trends in Schedule II opioid use and doctor shopping during 1999-2007 in California. Pharmacoepidemiol Drug Saf 2014;23:26.
24. Wang KH, BeckerWC, Fiellin DA. Prevalence and correlates for nonmedical use of prescription opioids among urban and rural residents. Drug Alcohol Depend 2013;127:156.
25. Scientific Registry of Transplant Recipients (SRTR). Risk Adjustment Models. Available at: http://www.srtr.org/csr/current/modtabs.aspx. Accessed: November 11, 2013.
26. Levy AR, O'Brien BJ, Sellors C, et al. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol 2003;10:67.
27. Lau HS, de Boer A, Beuning KS, et al. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 1997;50:619.
28. Boethius G. Recording of drug prescriptions in the county of Jamtland, Sweden. II. Drug exposure of pregnant women in relation to course and outcome of pregnancy. Eur J Clin Pharmacol 1977;12:37.
29. Pereira J, Lawlor P, Vigano A, et al. Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing. J Pain Symptom Manage 2001;22:672.
30. Inturrisi CE, Lipman AG. Opioid analgesics. In: Ballantyne JC, Rathmell JP, eds. Bonica's Management of Pain Baltimore/Philadelphia: Lippincott Williams & Wilkins, 2010:1172.
31. Schaubel DE, Dykstra DM, Murray S, et al. Analytical approaches for transplant research, 2004. Am J Transplant 2005;5(4 Pt 2):950.